These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4148514)

  • 21. [Metabolism of oxaflumazine].
    Boissier JR; Gérardin A; Dumont C
    Ann Pharm Fr; 1972 Dec; 30(12):851-60. PubMed ID: 4148298
    [No Abstract]   [Full Text] [Related]  

  • 22. Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors.
    Gobert A; Di Cara B; Cistarelli L; Millan MJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):338-46. PubMed ID: 12649387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolism of EGYT-475, a new antidepressant agent, in rats.
    Guttmann A; Nagy J; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):123-8. PubMed ID: 3432157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolism of 1-n-butyl-5,5-diethylbarbituric acid (N-n-butyl barbital) in the rat.
    Vore M; Sweetman BJ; Bush JT
    J Pharmacol Exp Ther; 1974 Aug; 190(2):384-94. PubMed ID: 4449048
    [No Abstract]   [Full Text] [Related]  

  • 25. [The agonist of dopamine receptors piribedil in treatment of Parkinson's disease].
    Pilipovich AA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):83-90. PubMed ID: 28745677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on metabolism of alpha, alpha-diethyl-3,4-methylenedioxyphenylacetamide (Hoe 264) in guinea pigs].
    Volz M
    Arzneimittelforschung; 1973 Aug; 23(8):1024-7. PubMed ID: 4801019
    [No Abstract]   [Full Text] [Related]  

  • 27. Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.
    Perez-Lloret S; Rascol O
    CNS Drugs; 2016 Aug; 30(8):703-17. PubMed ID: 27344665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolism of piperonyl butoxide in the rat with 14C in the methylenedioxy or alpha-methylene group.
    Fishbein L; Falk HL; Fawkes J; Jordan S; Corbett B
    J Chromatogr; 1969 Apr; 41(1):61-79. PubMed ID: 5780866
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolism of the antidepressant azaphene in rats].
    Gortinskaia TV; Siniukhin VN; Ostroumova HG; Rozynov BV; Nyrkova VG
    Farmakol Toksikol; 1973; 36(5):673-7. PubMed ID: 4802265
    [No Abstract]   [Full Text] [Related]  

  • 30. Piribedil-induced anti-hypoxic protection in rats.
    Saligaut C; Moore N; Daoust M; Chretien P; Boismare F
    Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
    Thobois S; Lhommée E; Klinger H; Ardouin C; Schmitt E; Bichon A; Kistner A; Castrioto A; Xie J; Fraix V; Pelissier P; Chabardes S; Mertens P; Quesada JL; Bosson JL; Pollak P; Broussolle E; Krack P
    Brain; 2013 May; 136(Pt 5):1568-77. PubMed ID: 23543483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolism of phenylbutazone in the rat.
    Bakke OM; Draffan GH; Davies DS
    Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132
    [No Abstract]   [Full Text] [Related]  

  • 33. [Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)].
    Babeau P; Pras P; Serizet A
    Sem Hop; 1980 Jan 18-25; 56(3-4):188-92. PubMed ID: 6244655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
    Rinne UK; Sonninen V; Marttila R
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the metabolism of eprazinone (author's transl)].
    Toffel-Nadolny P; Gielsdorf W
    Arzneimittelforschung; 1981; 31(4):719-22. PubMed ID: 7195719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical studies of dopaminergic mechanisms.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 12(0):427-34. PubMed ID: 4421041
    [No Abstract]   [Full Text] [Related]  

  • 37. The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
    Turle-Lorenzo N; Maurin B; Puma C; Chezaubernard C; Morain P; Baunez C; Nieoullon A; Amalric M
    J Pharmacol Exp Ther; 2006 Nov; 319(2):914-23. PubMed ID: 16920993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The incorporation of essential phospholipids into the organs of intact and galactosamine intoxicated rats].
    Lekim D; Betzing H
    Arzneimittelforschung; 1974 Aug; 24(8):1217-21. PubMed ID: 4479326
    [No Abstract]   [Full Text] [Related]  

  • 39. Photometric assay of hepatic epoxide hydrolase activity with safrole oxide (SAFO) as substrate.
    Watabe T; Akamatsu K
    Biochem Pharmacol; 1974 Oct; 23(20):2839-44. PubMed ID: 4429587
    [No Abstract]   [Full Text] [Related]  

  • 40. Radio gas chromatography of drug metabolites in tissue extracts.
    Neumann HG; Schenk J
    Xenobiotica; 1973 Jul; 3(7):435-50. PubMed ID: 4750621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.